News tagged with lamotrigine
Fetal exposure to antiepileptic drug valproate impairs cognitive development
(Medical Xpress)—The effects of antiepileptic drugs during pregnancy have long been a concern of clinicians and women of childbearing age whose seizures can only be controlled by medications. In 1999, a ...
Neuroscience
Mar 20, 2013 |
5 / 5 (1) |
0
|
Study reveals long-term effects on child IQ of epilepsy drug valproate during pregnancy
Research published today in the Lancet Neurology shows that taking the antiepileptic drug valproate during pregnancy affects the IQ of children up to the age of six.
Medications
Jan 22, 2013 |
not rated yet |
0
|
Study raises questions about use of anti-epilepsy drugs in newborns
A brain study in infant rats demonstrates that the anti-epilepsy drug phenobarbital stunts neuronal growth, which could prompt new questions about using the first-line drug to treat epilepsy in human newborns.
Neuroscience
May 11, 2012 |
not rated yet |
0
|
Study finds superior drug combo for difficult-to-control epilepsy
A combination of two common drugs, lamotrigine and valproate, is more effective in treating difficult-to control epilepsy than other anti-epileptic regimens, according to a University of Washington report to be published ...
Neuroscience
Dec 14, 2011 |
not rated yet |
0
|
Exposure to antiepileptic drug in womb linked to autism risk
Children whose mothers take the antiepileptic drug sodium valproate while pregnant are at significantly increased risk of autism and other neurodevelopmental disorders, suggests a small study published online in the Journal of ...
Autism spectrum disorders
Jan 30, 2013 |
1 / 5 (1) |
0
Prenatal use of newer antiepileptic drugs not associated with increased risk of major birth defects
Use of newer-generation antiepileptic drugs, which are also prescribed for bipolar mood disorders and migraine headaches, during the first trimester of pregnancy was not associated with an increased risk of major birth defects ...
Health
May 17, 2011 |
not rated yet |
0
Perampanel for epilepsy: No proof of added benefit
The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In an early benefit assessment according ...
Medications
Jan 30, 2013 |
not rated yet |
0
A more ethical way to compare epilepsy treatments
For the first time, a new research methodology recently approved by the Food and Drug Administration has been used to demonstrate that converting patients from one anti-epileptic drug to another - in this case, lamotrigine ...
Neuroscience
Dec 05, 2011 |
not rated yet |
0
